Smart Inhalers Market Share, Size, Value Analysis 2028

report image

Smart Inhalers Market to 2027 - Global Analysis and Forecasts By Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD) and Asthma); End User (Home-Care Settings and Hospitals & Clinics) and Geography

Publication Month: Jun 2019 | Report Code: TIPRE00004568 | No. of Pages: 144 | Category: Medical Device | Status: Published

The Smart Inhalers in healthcare market was valued at US$ 1,094.26million in 2018 and it is projected to reach US$ 8,033.21million by 2027; it is expected to grow at a CAGR of 25.5% from 2019 to 2027.

Smart inhalers are advanced form of inhalers that are digitally connected to apps on phone or tablet, which helps the physicians to manage patient’s medical condition more effectively. Smart inhalers use Bluetooth technology to identify the use of inhaler as well as remind patients to take their medication and gather data to help guide care. Other than the management of respiratory diseases, the device also sends an alert on smartphones when a patient enters a high pollen or highly polluted area, which helps a patient decide whether to avoid the environment. Smart inhalers have sensors, enabling the patients to automatically track how often the inhaler is being used by the patient, hence avoiding the chances of any human errors. The growth of the Smart Inhalers in healthcare market is attributed to the rising prevalence of asthma and COPD across the globe and growing geriatric population in regions such as Asia, Europe and North America are expected to boost are the key driving factors for the growth of the market in the forecast period. However, the growth of the market is restrained by factors such as limited knowledge regarding the use of smart inhalers and the risks associated with cyber threats.

The Smart Inhalers in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Smart Inhalers in Healthcare Market

Lucrative Regions for Smart Inhalers in Healthcare Market

Get more information on this report :

Market Insights

Growing Applications of Smart Inhalers in Healthcare to Drive Smart Inhalers in Healthcare Market Growth

With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the globe. Some of the factors leading to growth in the number of asthma and COPD cases across the globe are rise in air pollution levels and increasing smoking habits.

The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies. As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants. Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into lungs and the cardiovascular system. This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others. Studies reveal, above 90% of air pollution-related deaths worldwide occur in low- and middle-income countries, especially in Asian and African countries, followed by low- and middleincome countries of the Eastern Mediterranean, European and the American regions. For instance, in Brazil, there has been a rising concern regarding the air pollution levels. Air pollution kills about 49,000 Brazilians every year. Out of which around 25,000 deaths are caused due to outdoor pollution, whereas 24,000 deaths are a result of indoor pollution due to cooking using wood or other solid fuels. Deaths due to both outdoor and indoor air pollution represents approximately one in every 26 deaths from all the causes of death in Brazil, making it the ninth largest mortality risk in the country.

Additionally, increase in smoking habits is highly associated with increase in the number of cases of asthma. As per data published by the Centers for Disease Control and Prevention (CDC), Cigarette smoking is among the leading cause of preventable disease as well as death in the United States, causing more than 480,000 deaths every year, (i.e. about 1 in 5 deaths). During 2017, around 14 out of 100 adults aged 18 years and above in the United States have smoked cigarettes, i.e. an estimated 34.3 million adults in the United States. Hence, the rising levels of air pollution coupled with increasing smoking habits is anticipated to drive the demand for smart inhalers market during the forecast period.

The cases of asthma and COPD has been increasing across the globe at a significant rate. During recent years, there has been rise in the number of smokers as well as air pollution in developed as well as developing countries across the globe. Asthma is a non-communicable disease categorized by recurrent attacks of breathlessness and wheezing, which differ in severity and frequency from person to person. While an asthma attack occurs, the lining of the bronchial tubes swells, affecting the airways to narrow, hence limiting the flow of air into and out of the lungs. Recurrent asthma symptoms frequently lead to feeling of daytime fatigue, sleeplessness, reduced activity levels and school and work absence. As per estimates provided by the WHO, there are currently 235 million people suffering from asthma across the globe. As per the Centers for Disease Control and Prevention (CDC), the number of adults above 18 years of age currently having asthma are approximately 19 million in the United States, accounting for almost 7.7% of the total adult population. Whereas, the number of individuals below 18 years of age suffering from asthma is 6.2 million, accounting for 8.4% of the total children population. Also, as per the WHO estimates published during December 2016, there were 383 000 deaths due to asthma in 2015.

Similarly, there has been rising prevalence of COPD across the globe. Chronic obstructive pulmonary disease (COPD) is a progressive fatal lung disease that leads to breathlessness, leading to predisposes then exacerbations and later causes serious illness. As per the Global Burden of Disease Study report, a prevalence of around 251 million cases of COPD were recorded globally during the year 2016. It is estimated that globally approximately 3.17 million deaths were caused due to COPD during the year 2015, accounting for almost 5% of all deaths in 2015. The prevalence of COPD has been high in developed nations during the recent years. For instance, COPD is recognized as the third leading cause of death by disease in the United States. More than 11 million people have been diagnosed with COPD. Hence, the rising prevalence of respiratory conditions such as asthma and COPD is anticipated to fuel the growth of the smart inhalers market across the globe at an exponential rate.. COPD and asthma is a senescence condition, which leads to gradual complications. Asthma in older adults is a critical condition that often goes unnoticed, as per the Asthma and Allergy Foundation of America (AAFA). According to the Office of Disease Prevention and Health Promotion (ODPHP), approximately 23 million people in the U.S. have some form of asthma, most of which include the older population. Older people with asthma often need high doses of medication, in spite of mild asthma attacks. Hence, they are more likely to suffer from respiratory failure much faster as compared to the younger population. Also, COPD can appear at any age, however it is more prevalent in older population and can be fatal. Ageing population is growing exponentially worldwide. According to a report of United Nation (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 2050. The number of geriatric population is expected to grow significantly in Africa followed by North America, Latin America & the Caribbean, and Asia Pacific region.

The elderly people are more likely to have COPD and asthma than younger people, and the effect of the disease on quality of life is particularly deep in this population. With increase in the number of geriatric population, the prevalence of the COPD and asthma has increased significantly. Therefore, the demand for smart inhalers market is expected to increase in the forecast period.

Product-Based Insights

In terms of product, the Smart Inhalers in healthcare market is segmented into nebulizers and inhalers. In 2018, the inhalers segment held a largest market share 78.48% of the smart inhalers market, by product.

Smart Inhalers in Healthcare Market, by Product – 2018 and 2027

Smart Inhalers in Healthcare Market, by Product – 2018 and 2027

Get more information on this report :

Disorders-Based Insights

Based on disorders, the Smart Inhalers in healthcare market is segmented into chronic obstructive pulmonary disease (copd), and asthma. In 2018, the asthma segment held a largest market share 83.63% of the smart inhalers market, by disorder.

End User-Based Insights

In terms of end user, the Smart Inhalers in healthcare market is segmented into homecare settings, hospitals & clinics. The hospitals & healthcare providers segment held the largest share of the market in 2019, and it is further estimated to register the highest CAGR during the forecast period.

Strategic Insights

Report Coverage - Smart Inhalers Market
Report CoverageDetails
Market Size Value inUS$ 1,094.26Million in 2018
Market Size Value byUS$ 8,033.21Million by 2027
Growth rateCAGR of 25.5% from 2019-2027
Forecast Period2019-2027
Base Year2019
No. of Pages144
No. of Tables63
No. of Charts & Figures59
Historical data availableYes
Segments coveredProduct ; Disorder and Asthma); End User and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

The Smart Inhalers in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Smart Inhalers in Healthcare Market – by Product

  • Inhalers
  • Nebulizers

Smart Inhalers in Healthcare Market – by Disorders

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)  

Smart Inhalers in Healthcare Market – by End User

  • Home-Care Settings
  • Hospitals & Clinics

Smart Inhalers in Healthcare Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • GlaxoSmithKline plc
  • Adherium Ltd.
  • Vectura Group plc
  • Novartis AG
  • Findair Sp. z o. o.
  • Cohero Health
  • Crux Product Design Ltd
  • Teva Pharmaceuticals
  • 3M
  • Amiko Digital Health Limited

The List of Companies

  1. GlaxoSmithKline plc
  2. Adherium Ltd.
  3. Vectura Group plc
  4. Novartis AG
  5. Findair Sp. z o. o.
  6. Cohero Health
  7. Crux Product Design Ltd
  8. Teva Pharmaceuticals
  9. 3M
  10. Amiko Digital Health Limited
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the smart inhalers market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global smart inhalers market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount